BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services Contract Manufacturing

Ajinomoto Bio-Pharma Services Sweeps CDMO Leadership Awards in Unprecedented Six-Category Win

Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, received CDMO Le...

March 13, 2024 | News

SK bioscience and Sanofi to Boost Global Vaccine Supply with Major Expansion of L HOUSE Manufacturing Plant

The company will expand its manufacturing plant, L HOUSE, with additional cGMP-level facility. The new space will serve as a production base for the pne...

March 08, 2024 | News

Suven Pharmaceuticals Joins Forces with Cohance Lifesciences in Transformative Merger to Strengthen CDMO Dominance

Transformative Merger with 2x Scale and Double-Digit EPS Accretion in the first year Suven poised to become a leading integrated CDMO player...

March 01, 2024 | News

BioCina and NovaCina Join Forces for Integrated Biologics Solutions

BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organisation (CDMO), and NovaCina Pty Ltd., a global fill-and-finish...

February 28, 2024 | News

GC Cell and BioCentriq® Execute Process Transfer Agreement in Anticipation of the U.S. entry of Immuncell-LC Inj

Immuncell-LC Inj. is an autologous Cytokine Induced Killer (CIK) cell therapy approved for Commercial use in South Korea as an adjuvant cell th...

February 27, 2024 | News

Charles River and Wheeler Bio Forge Strategic Alliance to Streamline Drug Development Process

This partnership aims to enhance therapeutic discovery and expedite the journey to Investigational New Drug (IND) submission by combining Charles R...

February 23, 2024 | News

WuXi Advanced Therapies Receives FDA Approval to Manufacture Iovance's AMTAGVI™ (lifileucel) for Advanced Melanoma

WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, today announced that the U.S. Food and Dr...

February 21, 2024 | News

Samsung Biologics and LegoChem Biosciences Forge Strategic Partnership for ADC Development and Manufacturing

The collaboration marks a pivotal milestone as Samsung Biologics commits to providing cutting-edge antibody development and drug substance manufact...

February 12, 2024 | News

Novo Nordisk's Investment Arm, Novo Holdings, Seals $16.5 Billion Deal to Acquire Catalent in All-Cash Transaction

Catalent, Inc. (NYSE: CTLT), a prominent player in advancing global patient treatment solutions, and Novo Holdings, a holding and investment entity oversee...

February 06, 2024 | News

WuXi Biologics Achieves Milestone with 16,000L Manufacturing Run in Ireland

First manufacturing run successful for MFG7 facility at the Ireland site Largest manufacturing scale to date achieved by combining four 4,000-liter sing...

February 01, 2024 | News

WuXi XDC Partners with Multitude and HySlink for Accelerated ADC Discovery and Development

WuXi XDC will provide a fully integrated, one-stop bioconjugate platform and end-to-end CRDMO services. As WuXi XDC's strategic partner, Multitude Therapeu...

January 31, 2024 | News

WuXi XDC and Celltrion Collaborate on Comprehensive Antibody-Drug Conjugate (ADC) Services

Under the collaboration, Celltrion will delegate WuXi XDC as primary service provider on each of the integrated projects, from process development to GMP m...

January 24, 2024 | News

Kindeva Drug Delivery Acquires Summit Biosciences, a Nasal Drug Development Specialist

The acquisition of Summit enhances Kindeva’s existing drug-delivery capabilities by adding a new drug-delivery platform, further expanding Kindeva&rs...

January 19, 2024 | News

Vetter Joins German Research-Based Pharma Association (vfa)

Association grants Vetter extraordinary membership vfa recognizes the importance of pharmaceutical service providers in drug development and production ...

January 18, 2024 | News

Stay Connected